Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze FNWD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate FNWD investment potential.

What is FNWD stock price today?

Get real-time FNWD stock price, historical data, and price charts on Financhill. Track FNWD performance with our advanced analysis tools.

Is FNWD a good investment?

Evaluate FNWD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy FNWD stock?

To buy FNWD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of FNWD?

View detailed market capitalization data and company valuation metrics for FNWD on our comprehensive analysis page.

What is the P/E ratio of FNWD?

Use our fundamental analysis tools to view FNWD P/E ratio and compare valuation metrics with industry peers.

What are FNWD earnings?

View FNWD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Finward Bancorp 10K Form

Buy

FNWD
Finward Bancorp

Last Price:

$37.86

Seasonality Move:

2.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-05-07	10Q	FNWD/Finward Bancorp Quarterly
2021-03-22	10K	FNWD/Finward Bancorp Annual
2020-08-07	10Q	FNWD/Finward Bancorp Quarterly
2020-03-16	10K	FNWD/Finward Bancorp Annual
2019-03-05	10K	FNWD/Finward Bancorp Annual
2018-07-24	10Q	FNWD/Finward Bancorp Quarterly

Receive FNWD News And Ratings

See the #1 stock for the next 7 days that we like better than FNWD

FNWD Financial Statistics

Sales & Book Value

Annual Sales:	$111.5M
Cash Flow:	$1M
Price / Cash Flow:	13.67
Annual Sales:	$38.24
Price / Book:	0.99

Profitability

EPS (TTM):	1.90750
Net Income (TTM):	$8.2M
Gross Margin:	$0
Return on Equity:	5.24%
Return on Assets:	0.4%

Finward Bancorp Earnings Forecast

Key Finward Bancorp Financial Ratios

The Gross Profit Margin over the past 32 years for FNWD is 0.00%.
The Selling, General & Administrative Expenses for FNWD have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 32.72% of Operating Income.
The Net Earning history of FNWD is 10.88% of Total Revenues.
Per Share Earnings over the last 32 years have been positive in 21 years.

Finward Bancorp Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Banks
Sector:	Financials
Current Symbol:	FNWD
Website:	ibankpeoples.com

Debt

Debt-to-Equity Ratio:	0.62
Current Ratio:	0.11
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	13.4
Forward P/E Ratio:	14.6

FNWD Technical Analysis vs Fundamental Analysis

Buy

Finward Bancorp (FNWD) is a Buy

Is Finward Bancorp a Buy or a Sell?

Finward Bancorp stock is rated a Buy

The current Finward Bancorp [FNWD] share price is $38.02. The Score for FNWD is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.